SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Donald Gravenor who wrote (77)2/14/1997 9:09:00 AM
From: George Mc Geary   of 1321
 
BPD for AMD is driving force behind this stock.

Don I agree with your input. The lung cancer treatment approval will be great for mankind, QLTIF and its shareholders. However, the potential projections for BPD is $600 Million in the US alone. This projection was made about a year ago and was about 3 times the projection for the cancer treatment drugs.

Any projections on revenues if and when the NDA for lung cancer is approved?

Any one have any numbers for future earnings on QLTIF. the last I had heard was that they expect a loss of about $.33 for '97 and a earnings of about $.17 for '98.

I have owned this since Jan of 93.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News